Get the latest Science News and Discoveries
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial - EurekAlert
ccording to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.
None
Or read this on Eureka Alert